Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure
In today’s Pharmaceutical Executive Daily learn how Novo Nordisk is restructuring leadership to enhance scientific and commercial alignment, ABL Bio …
7 months, 3 weeks ago
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA unveils a new Plausible…
8 months ago
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
In today’s Pharmaceutical Executive Daily, Richard Pazdur is named director of FDA’s Center for Drug Evaluation and Research, Pfizer strengthens focu…
8 months ago
Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock
In today’s Pharmaceutical Executive Daily, AstraZeneca surpasses Shell to become the UK’s largest listed company, Basel intensifies efforts to attrac…
8 months ago
Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients
8 months ago
Raising Biomarker Awareness
Dr. Jaspal Singh explains some of the barriers that prevent cancer patients from getting biomarker testing early in their treatment journey.
8 months ago
Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro
In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Darzalex Faspro for adults with high-risk smoldering multiple myeloma, the …
8 months ago
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1's to TrumpRX
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the TrumpRx …
8 months, 1 week ago
Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Kenvue’s…
8 months, 1 week ago
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 billion investment to strength…
8 months, 1 week ago